Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1992-6-11
pubmed:abstractText
Ribophorins I and II are type I transmembrane glycoproteins of the ER that are segregated to the rough domains of this organelle. Both ribophorins appear to be part of the translocation apparatus for nascent polypeptides that is associated with membrane-bound ribosomes and participate in the formation of a proteinaceous network within the ER membrane that also includes other components of the translocation apparatus. The ribophorins are both highly stable proteins that lack O-linked sugars but each contains one high mannose N-linked oligosaccharide that remains endo H sensitive throughout their lifetimes. We have previously shown (Tsao, Y. S., N. E. Ivessa, M. Adesnik, D. D. Sabatini, and G. Kreibich. 1992. J. Cell Biol. 116:57-67) that a COOH-terminally truncated variant of ribophorin I that contains only the first 332 amino acids of the luminal domain (RI332), when synthesized in permanent transformants of HeLa cells, undergoes a rapid degradation with biphasic kinetics in the ER itself and in a second, as yet unidentified nonlysosomal pre-Golgi compartment. We now show that in cells treated with brefeldin A (BFA) RI332 molecules undergo rapid O-glycosylation in a multistep process that involves the sequential addition of N-acetylgalactosamine, galactose, and terminal sialic acid residues. Addition of O-linked sugars affected all newly synthesized RI332 molecules and was completed soon after synthesis with a half time of about 10 min. In the same cells, intact ribophorins I and II also underwent O-linked glycosylation in the presence of BFA, but these molecules were modified only during a short time period immediately after their synthesis was completed, and the modification affected only a fraction of the newly synthesized polypeptides. More important, these molecules synthesized before the addition of BFA were not modified by O-glycosylation. The same is true for ribophorin I when overexpressed in HeLa cells although it is significantly less stable than the native polypeptide in control cells. We, therefore, conclude that soon after their synthesis, ribophorins lose their susceptibility to the relocated Golgi enzymes that effect the O-glycosylation, most likely as a consequence of a conformational change in the ribophorins that occurs during their maturation, although it cannot be excluded that rapid integration of these molecules into a supramolecular complex in the ER membrane leads to their inaccessibility to these enzymes.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-108267, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-1710116, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-1730749, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-1772654, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-1993732, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-2120038, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-2167898, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-2178778, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-21877, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-2211814, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-2381327, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-2527615, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-2602384, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-2647301, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-2688704, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-2745557, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-2780556, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-2836431, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-2925690, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-2954653, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-3031084, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-3034581, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-3041222, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-3192548, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-3288098, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-3301866, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-3552922, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-3896128, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-3932365, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-4055894, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-418074, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-4299889, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-489569, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-6035647, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-6194163, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-6317691, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-6429158, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-6435119, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-6470038, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-649658, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-6501423, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-6501424, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-6656642, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-6924936, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-701363, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-701364, http://linkedlifedata.com/resource/pubmed/commentcorrection/1577870-7440248
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0021-9525
pubmed:author
pubmed:issnType
Print
pubmed:volume
117
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
949-58
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1992
pubmed:articleTitle
O-glycosylation of intact and truncated ribophorins in brefeldin A-treated cells: newly synthesized intact ribophorins are only transiently accessible to the relocated glycosyltransferases.
pubmed:affiliation
Department of Cell Biology, New York University School of Medicine, New York 10016.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.
More...